Whether you are in pharmaceuticals, veterinary drugs, medical devices, diagnostics, biotechnology, life sciences research, plant biology, crop science, agriculture, or ‘border’ products such as nutraceuticals, food supplements and food products — Dentons knows your business.
Every day, we help life sciences clients decide how best to face the challenges in developing and commercialising products, delivering services, and capitalising on scientific breakthroughs and business opportunities around the globe. In addition to our lawyers’ seamless collaboration worldwide, we work closely with research institutes, leaders in scientific opinion, pharma-economic and medical experts and management advisers to provide the well-rounded, commercially focused service you need.
When you need capital, we are there. Our lawyers have participated in numerous public offerings, venture capital investments, mergers and acquisitions, leveraged buyouts, technology transfer transactions, university spin-offs and initial financing transactions.
Need to capitalise on your innovations? We have structured complex licensing, distribution, co-promotion, development and manufacturing agreements. From research and development through manufacturing, protection of intellectual property and patients’ consent, marketing and sales, we provide the knowledge and support you need to keep projects moving, while mitigating risks to help you steer clear of costly delays and complications.
When compliance issues, investigations, litigation, or problems with anti-gift, anti-corruption and transparency regulations threaten to take you away from the business of improving health, our unparalleled preparation and in-depth knowledge of the law, regulations and your business takes the weight off your shoulders.
This information was sourced from the Dentons website.
News from Dentons
News from The Lawyer
Briefings from Dentons
Conclusion of new agreements between shareholders of Ukrainian joint-stock companies and depository institutions
On 12 October 2014, a year will have passed since the Law of Ukraine ‘On the Depository System of Ukraine’ No. 5178-VI entered into force.
Earlier this year, McKesson Canada Corporation appealed the decision of the Tax Court of Canada in McKesson Canada Corporation v The Queen.
Analysis from The Lawyer
The continent’s boom in natural resources and renewable energy is sparking an infrastructure drive
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.